Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 142

References for PMC Articles for PubMed (Select 22991685)

1.

Targeting NADPH oxidases in vascular pharmacology.

Schramm A, Matusik P, Osmenda G, Guzik TJ.

Vascul Pharmacol. 2012 May-Jun;56(5-6):216-31. doi: 10.1016/j.vph.2012.02.012. Epub 2012 Mar 3. Review.

2.

Apolipoprotein E predicts incident cardiovascular disease risk in women but not in men with concurrently high levels of high-density lipoprotein cholesterol and C-reactive protein.

Corsetti JP, Gansevoort RT, Bakker SJ, Navis G, Sparks CE, Dullaart RP.

Metabolism. 2012 Jul;61(7):996-1002. doi: 10.1016/j.metabol.2011.11.010. Epub 2012 Jan 5.

3.

Thrombospondin-4 polymorphism (A387P) predicts cardiovascular risk in postinfarction patients with high HDL cholesterol and C-reactive protein levels.

Corsetti JP, Ryan D, Moss AJ, McCarthy J, Goldenberg I, Zareba W, Sparks CE.

Thromb Haemost. 2011 Dec;106(6):1170-8. doi: 10.1160/TH11-03-0206. Epub 2011 Oct 20.

PMID:
22011848
4.

Pathophysiological roles of NADPH oxidase/nox family proteins in the vascular system. -Review and perspective-.

Ago T, Kuroda J, Kamouchi M, Sadoshima J, Kitazono T.

Circ J. 2011;75(8):1791-800. Epub 2011 Jun 15. Review.

5.

Vitamins C and E: beneficial effects from a mechanistic perspective.

Traber MG, Stevens JF.

Free Radic Biol Med. 2011 Sep 1;51(5):1000-13. doi: 10.1016/j.freeradbiomed.2011.05.017. Epub 2011 May 25. Review.

6.

PKCζ mediates disturbed flow-induced endothelial apoptosis via p53 SUMOylation.

Heo KS, Lee H, Nigro P, Thomas T, Le NT, Chang E, McClain C, Reinhart-King CA, King MR, Berk BC, Fujiwara K, Woo CH, Abe J.

J Cell Biol. 2011 May 30;193(5):867-84. doi: 10.1083/jcb.201010051.

7.

Imagine how many lives you save: angiotensin-converting enzyme inhibition for atherosclerotic vascular disease in the present era of risk reduction.

Ennezat PV, Vannesson C, Bouabdallaoui N, Maréchaux S, Asseman P, LeJemtel TH.

Expert Opin Pharmacother. 2011 Apr;12(6):883-97. doi: 10.1517/14656566.2011.543675. Epub 2011 Feb 24. Review.

PMID:
21348772
8.

LPL polymorphism (D9N) predicts cardiovascular disease risk directly and through interaction with CETP polymorphism (TaqIB) in women with high HDL cholesterol and CRP.

Corsetti JP, Gansevoort RT, Navis G, Sparks CE, Dullaart RP.

Atherosclerosis. 2011 Feb;214(2):373-6. doi: 10.1016/j.atherosclerosis.2010.11.029. Epub 2010 Nov 26.

9.

MK2 SUMOylation regulates actin filament remodeling and subsequent migration in endothelial cells by inhibiting MK2 kinase and HSP27 phosphorylation.

Chang E, Heo KS, Woo CH, Lee H, Le NT, Thomas TN, Fujiwara K, Abe J.

Blood. 2011 Feb 24;117(8):2527-37. doi: 10.1182/blood-2010-08-302281. Epub 2010 Dec 3.

10.

p53 impairs endothelial function by transcriptionally repressing Kruppel-Like Factor 2.

Kumar A, Kim CS, Hoffman TA, Naqvi A, Dericco J, Jung SB, Lin Z, Jain MK, Irani K.

Arterioscler Thromb Vasc Biol. 2011 Jan;31(1):133-41. doi: 10.1161/ATVBAHA.110.215061. Epub 2010 Oct 14.

11.

Inflammatory markers, cholesterol and statins: pathophysiological role and clinical importance.

Biasucci LM, Biasillo G, Stefanelli A.

Clin Chem Lab Med. 2010 Dec;48(12):1685-91. doi: 10.1515/CCLM.2010.277. Epub 2010 Sep 27. Review.

PMID:
20868311
12.

Oxidative stress as a mediator of cardiovascular disease.

Elahi MM, Kong YX, Matata BM.

Oxid Med Cell Longev. 2009 Nov-Dec;2(5):259-69. doi: 10.4161/oxim.2.5.9441. Review.

13.

Low-grade inflammation, and dysfunction of high-density lipoprotein and its apolipoproteins as a major driver of cardiometabolic risk.

Onat A, Hergenç G.

Metabolism. 2011 Apr;60(4):499-512. doi: 10.1016/j.metabol.2010.04.018. Epub 2010 May 23. Review.

PMID:
20580781
14.

Discovery of novel mechanosensitive genes in vivo using mouse carotid artery endothelium exposed to disturbed flow.

Ni CW, Qiu H, Rezvan A, Kwon K, Nam D, Son DJ, Visvader JE, Jo H.

Blood. 2010 Oct 14;116(15):e66-73. doi: 10.1182/blood-2010-04-278192. Epub 2010 Jun 15.

15.

Dysfunctional high-density lipoprotein and atherosclerosis.

Ragbir S, Farmer JA.

Curr Atheroscler Rep. 2010 Sep;12(5):343-8. doi: 10.1007/s11883-010-0091-x. Review.

PMID:
20506005
16.

Cholesteryl ester transfer protein polymorphism (TaqIB) associates with risk in postinfarction patients with high C-reactive protein and high-density lipoprotein cholesterol levels.

Corsetti JP, Ryan D, Rainwater DL, Moss AJ, Zareba W, Sparks CE.

Arterioscler Thromb Vasc Biol. 2010 Aug;30(8):1657-64. doi: 10.1161/ATVBAHA.110.207977. Epub 2010 May 20.

17.

Captopril reduces cardiac inflammatory markers in spontaneously hypertensive rats by inactivation of NF-kB.

Miguel-Carrasco JL, Zambrano S, Blanca AJ, Mate A, Vázquez CM.

J Inflamm (Lond). 2010 May 12;7:21. doi: 10.1186/1476-9255-7-21.

18.

NADPH oxidases in cardiovascular disease.

Brandes RP, Weissmann N, Schröder K.

Free Radic Biol Med. 2010 Sep 1;49(5):687-706. doi: 10.1016/j.freeradbiomed.2010.04.030. Epub 2010 May 2. Review.

PMID:
20444433
19.

Inflammation reduces HDL protection against primary cardiac risk.

Corsetti JP, Gansevoort RT, Sparks CE, Dullaart RP.

Eur J Clin Invest. 2010 Jun;40(6):483-9. doi: 10.1111/j.1365-2362.2010.02287.x. Epub 2010 Apr 14.

PMID:
20412290
20.

Oxidative stress and hypertension.

Harrison DG, Gongora MC, Guzik TJ, Widder J.

J Am Soc Hypertens. 2007 Jan-Feb;1(1):30-44. doi: 10.1016/j.jash.2006.11.006.

PMID:
20409831
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk